美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA214956"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
71610-753-70 71610-753 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20231130 N/A ANDA ANDA214956 Aphena Pharma Solutions - Tennessee, LLC GABAPENTIN 300 mg/1 120 CAPSULE in 1 BOTTLE (71610-753-70)
71610-753-94 71610-753 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20231116 N/A ANDA ANDA214956 Aphena Pharma Solutions - Tennessee, LLC GABAPENTIN 300 mg/1 360 CAPSULE in 1 BOTTLE (71610-753-94)
71610-753-98 71610-753 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20231208 N/A ANDA ANDA214956 Aphena Pharma Solutions - Tennessee, LLC GABAPENTIN 300 mg/1 540 CAPSULE in 1 BOTTLE (71610-753-98)
71610-756-53 71610-756 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20231128 N/A ANDA ANDA214956 Aphena Pharma Solutions - Tennessee, LLC GABAPENTIN 100 mg/1 60 CAPSULE in 1 BOTTLE (71610-756-53)
71610-757-80 71610-757 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20231128 N/A ANDA ANDA214956 Aphena Pharma Solutions - Tennessee, LLC GABAPENTIN 400 mg/1 180 CAPSULE in 1 BOTTLE (71610-757-80)
71610-757-94 71610-757 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20240103 N/A ANDA ANDA214956 Aphena Pharma Solutions - Tennessee, LLC GABAPENTIN 400 mg/1 360 CAPSULE in 1 BOTTLE (71610-757-94)
71610-757-53 71610-757 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20231128 N/A ANDA ANDA214956 Aphena Pharma Solutions - Tennessee, LLC GABAPENTIN 400 mg/1 60 CAPSULE in 1 BOTTLE (71610-757-53)
71610-757-60 71610-757 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20240103 N/A ANDA ANDA214956 Aphena Pharma Solutions - Tennessee, LLC GABAPENTIN 400 mg/1 90 CAPSULE in 1 BOTTLE (71610-757-60)
71610-756-30 71610-756 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20231128 N/A ANDA ANDA214956 Aphena Pharma Solutions - Tennessee, LLC GABAPENTIN 100 mg/1 30 CAPSULE in 1 BOTTLE (71610-756-30)
43602-469-10 43602-469 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20210510 N/A ANDA ANDA214956 Ascent Pharmaceuticals, Inc GABAPENTIN 100 mg/1 1000 CAPSULE in 1 BOTTLE (43602-469-10)
43602-471-05 43602-471 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20210510 N/A ANDA ANDA214956 Ascent Pharmaceuticals, Inc GABAPENTIN 400 mg/1 500 CAPSULE in 1 BOTTLE (43602-471-05)
43602-471-30 43602-471 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20210510 N/A ANDA ANDA214956 Ascent Pharmaceuticals, Inc GABAPENTIN 400 mg/1 30 CAPSULE in 1 BOTTLE (43602-471-30)
43602-469-30 43602-469 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20210510 N/A ANDA ANDA214956 Ascent Pharmaceuticals, Inc GABAPENTIN 100 mg/1 30 CAPSULE in 1 BOTTLE (43602-469-30)
43602-470-05 43602-470 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20210510 N/A ANDA ANDA214956 Ascent Pharmaceuticals, Inc GABAPENTIN 300 mg/1 500 CAPSULE in 1 BOTTLE (43602-470-05)
43602-470-30 43602-470 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20210510 N/A ANDA ANDA214956 Ascent Pharmaceuticals, Inc GABAPENTIN 300 mg/1 30 CAPSULE in 1 BOTTLE (43602-470-30)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase